Enveric Biosciences (ENVB) announced that it has received a notice of allowance from the United States Patent and Trademark Office for a patent application pertaining to its EVM401 Series of molecules being developed as potential treatments for mental health disorders.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ENVB: